The Verzenio Market is experiencing remarkable growth, driven by its expanding use in metastatic breast cancer treatment. Valued at USD 3.8 Billion in 2023, the market is projected to reach USD 126.5 Billion by 2034, with a CAGR of 37.6% from 2024 to...
markspark.hashnode.dev1 min read
No responses yet.